Functional testing
- 1 January 1990
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 13 (S1) , S26-S29
- https://doi.org/10.1002/mus.880131309
Abstract
Functional testing is useful to monitor the natural history of several neuromuscular disorders, and to measure the efficacy of therapeutic agents in clinical trials. A major limitation of functional testing is that a single test is often not appropriate throughout all stages of disease. The same limitation holds true for other measurements of disease progression. MMT and quantitative myometry become technically difficult to perform and lack sensitivity to disease progression at some stages in the course of DMD, ALS, and spinal muscular atrophy. Other limitations of functional testing are its lack of sensitivity to detect a subtle improvement or decline in muscle strength, and the difficulty of applying standard statistical methods to analyze disease progression or therapeutic efficacy. The advantages of functional testing outweigh the limitations. Function testing uses daily activities to monitor disease progression. Patient's appreciate improvements in function more readily than improvements in muscle strength. Functional testing is easily standardized and is reliable. It can be performed, with little or no expense, in almost any clinical setting. The primary challenge for investigators who wish to incorporate functional tests is to identify functional tests that best measure the natural history of the specific disease under investigation. Further, functional testing allows the clinician to provide an educated guess on the likely future course of disease.Keywords
This publication has 11 references indexed in Scilit:
- Randomized, Double-Blind Six-Month Trial of Prednisone in Duchenne's Muscular DystrophyNew England Journal of Medicine, 1989
- Duchenne muscular dystrophyNeurology, 1989
- Randomized controlled trial of testosterone in myotonic dystrophyNeurology, 1989
- A rating scale for amyotrophic lateral sclerosis: Description and preliminary experienceAnnals of Neurology, 1987
- Quantitative motor assessment in amyotrophic lateral sclerosisNeurology, 1986
- Amyotrophic lateral sclerosisNeurology, 1986
- Controlled trial of thyrotropin releasing hormone in amyotrophic lateral sclerosisNeurology, 1986
- A double‐blind, placebo‐controlled trial of TRH in amyotrophic lateral sclerosisNeurology, 1986
- Clinical Trials in Duchenne DystrophyPTJ: Physical Therapy & Rehabilitation Journal, 1984
- Clinical investigation in duchenne dystrophy: 2. Determination of the “power” of therapeutic trials based on the natural historyMuscle & Nerve, 1983